- The plant will be operational by 2027 using a 'direct pathway' process.
- Basic engineering design and first tranche of €16.4 million financing expected by summer 2024.
- Front end engineering design (FEED) to be completed between 2025 and 2027.
- The plant will produce isobutene for cosmetics and sustainable aviation fuels.
Project Timeline
Global Bioenergies has announced a clearer schedule for the construction and commissioning of its new biobased isobutene plant in France, set to be operational by 2027. The production technology will utilize a "direct pathway" process, integrating the entire production chain and minimizing input requirements.
Engineering and Financing
The basic engineering design is expected to be finalized by summer 2024, alongside the signing of the first tranche of financing, which includes part of the €16.4 million awarded by Bpifrance under the France 2030 plan. Following this, the front end engineering design (FEED) will be completed to prepare for the plant's construction between 2025 and 2027.
Production Capabilities
This plant will be the first globally to convert plant-based resources into isobutene derivatives on a large scale, targeting the cosmetics market under the Isonaturane™ brand. Applications will range from make-up to skin care products.
Sustainable Aviation Fuels
The plant will also initiate the production of sustainable aviation fuels (SAF), for which Global Bioenergies obtained ASTM certification in June. This development will pave the way for constructing additional, larger plants dedicated to SAF, with a new site planned for commissioning by 2030, aligning with the European mandate for 6% SAF in all planes departing from European airports.
